EA200300460A1 - NEW DERIVATIVES m-AMINOPHENILIMINOIMIDAZOLIDINE FOR THE TREATMENT OF URINARY HOLDING - Google Patents
NEW DERIVATIVES m-AMINOPHENILIMINOIMIDAZOLIDINE FOR THE TREATMENT OF URINARY HOLDINGInfo
- Publication number
- EA200300460A1 EA200300460A1 EA200300460A EA200300460A EA200300460A1 EA 200300460 A1 EA200300460 A1 EA 200300460A1 EA 200300460 A EA200300460 A EA 200300460A EA 200300460 A EA200300460 A EA 200300460A EA 200300460 A1 EA200300460 A1 EA 200300460A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- denotes
- treatment
- cfh
- chf
- urinary
- Prior art date
Links
- 230000002485 urinary effect Effects 0.000 title 1
- QOBQHDFSJHQICB-UHFFFAOYSA-N 3-n-(4,5-dihydro-1h-imidazol-2-yl)benzene-1,3-diamine Chemical class NC1=CC=CC(NC=2NCCN=2)=C1 QOBQHDFSJHQICB-UHFFFAOYSA-N 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
В заявке описаны производные м-аминофенилиминоимидазолидина формулы (I) или формулы (II) с новой комбинацией заместителей в фенильном кольцегде Rобозначает F, Cl, Br, CHF, CFH или CF, Rобозначает NRR, где Rпредставляет собой Me, Et, Pr или изо-Pr, a Rпредставляет собой Me, Et или Pr, и R, R, R, каждый независимо друг от друга, обозначает H, Me, F, Cl, Br, CHF, CFH и/или CF, при этом в случае, когда Rобозначает Me, F, Cl, Br, CHF, CFH или CF, Rдополнительно обозначает также H или Me, и/или его фармакологически приемлемые соли, применение таких соединений для получения лекарственных средств, предназначенных прежде всего для лечения недержания мочи, и способ их получения.Отчет о международном поиске был опубликован 2002.07.18.The application describes m-aminophenyliminoimidazolidine derivatives of formula (I) or formula (II) with a new combination of substituents in the phenyl ring, where R denotes F, Cl, Br, CHF, CFH or CF, R N denotes RR, where R Pr, a R represents Me, Et or Pr, and R, R, R, each independently of one another, denotes H, Me, F, Cl, Br, CHF, CFH and / or CF, in which case R denotes Me, F, Cl, Br, CHF, CFH or CF, R is additionally also denotes H or Me, and / or its pharmacologically acceptable salts, the use of such compounds for the preparation of drugs, intended Primarily for the treatment of urinary incontinence, and the way they are obtained. The international search report was published 2002.07.18.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10051005 | 2000-10-14 | ||
| PCT/EP2001/011764 WO2002032876A2 (en) | 2000-10-14 | 2001-10-11 | Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200300460A1 true EA200300460A1 (en) | 2004-02-26 |
Family
ID=7659815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200300460A EA200300460A1 (en) | 2000-10-14 | 2001-10-11 | NEW DERIVATIVES m-AMINOPHENILIMINOIMIDAZOLIDINE FOR THE TREATMENT OF URINARY HOLDING |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1328517A2 (en) |
| JP (1) | JP2004511547A (en) |
| KR (1) | KR20030046503A (en) |
| CN (1) | CN1471514A (en) |
| AR (1) | AR035923A1 (en) |
| AU (1) | AU2002215943A1 (en) |
| BG (1) | BG107711A (en) |
| BR (1) | BR0114603A (en) |
| CA (1) | CA2425563A1 (en) |
| CZ (1) | CZ20031333A3 (en) |
| DE (1) | DE10150312A1 (en) |
| EA (1) | EA200300460A1 (en) |
| EC (1) | ECSP034517A (en) |
| EE (1) | EE200300177A (en) |
| HU (1) | HUP0302245A3 (en) |
| IL (1) | IL155338A0 (en) |
| MX (1) | MXPA03003162A (en) |
| NO (1) | NO20031697L (en) |
| PL (1) | PL361359A1 (en) |
| SK (1) | SK4342003A3 (en) |
| WO (1) | WO2002032876A2 (en) |
| YU (1) | YU28203A (en) |
| ZA (1) | ZA200302345B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4168086B1 (en) * | 2008-04-16 | 2008-10-22 | 国立大学法人福井大学 | Imidazoline derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2806811A1 (en) * | 1978-02-17 | 1979-08-23 | Boehringer Sohn Ingelheim | NEW SUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINE, THEIR ACID-ADDITIONAL SALTS, THESE MEDICINAL PRODUCTS AND METHOD FOR MANUFACTURING THE SAME |
| CA1201066A (en) * | 1981-11-20 | 1986-02-25 | Alcon Laboratories, Inc. | N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure |
| DE19514579A1 (en) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Use of alpha-1-olone agonists for the treatment of urinary incontinence |
-
2001
- 2001-10-11 SK SK434-2003A patent/SK4342003A3/en not_active Application Discontinuation
- 2001-10-11 CN CNA018170870A patent/CN1471514A/en active Pending
- 2001-10-11 EA EA200300460A patent/EA200300460A1/en unknown
- 2001-10-11 AU AU2002215943A patent/AU2002215943A1/en not_active Abandoned
- 2001-10-11 CZ CZ20031333A patent/CZ20031333A3/en unknown
- 2001-10-11 YU YU28203A patent/YU28203A/en unknown
- 2001-10-11 MX MXPA03003162A patent/MXPA03003162A/en unknown
- 2001-10-11 PL PL01361359A patent/PL361359A1/en not_active Application Discontinuation
- 2001-10-11 HU HU0302245A patent/HUP0302245A3/en unknown
- 2001-10-11 EP EP01987747A patent/EP1328517A2/en not_active Withdrawn
- 2001-10-11 WO PCT/EP2001/011764 patent/WO2002032876A2/en not_active Ceased
- 2001-10-11 KR KR10-2003-7005143A patent/KR20030046503A/en not_active Withdrawn
- 2001-10-11 JP JP2002536060A patent/JP2004511547A/en active Pending
- 2001-10-11 IL IL15533801A patent/IL155338A0/en unknown
- 2001-10-11 EE EEP200300177A patent/EE200300177A/en unknown
- 2001-10-11 DE DE10150312A patent/DE10150312A1/en not_active Withdrawn
- 2001-10-11 BR BR0114603-3A patent/BR0114603A/en not_active IP Right Cessation
- 2001-10-11 CA CA002425563A patent/CA2425563A1/en not_active Abandoned
- 2001-10-12 AR ARP010104787A patent/AR035923A1/en not_active Application Discontinuation
-
2003
- 2003-03-17 EC EC2003004517A patent/ECSP034517A/en unknown
- 2003-03-26 ZA ZA200302345A patent/ZA200302345B/en unknown
- 2003-04-08 BG BG107711A patent/BG107711A/en unknown
- 2003-04-11 NO NO20031697A patent/NO20031697L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0302245A3 (en) | 2004-01-28 |
| BG107711A (en) | 2004-02-27 |
| CN1471514A (en) | 2004-01-28 |
| WO2002032876A3 (en) | 2002-07-18 |
| ECSP034517A (en) | 2003-04-25 |
| WO2002032876A2 (en) | 2002-04-25 |
| CA2425563A1 (en) | 2002-04-25 |
| HUP0302245A2 (en) | 2003-10-28 |
| ZA200302345B (en) | 2004-04-23 |
| NO20031697L (en) | 2003-05-26 |
| EE200300177A (en) | 2003-08-15 |
| KR20030046503A (en) | 2003-06-12 |
| EP1328517A2 (en) | 2003-07-23 |
| IL155338A0 (en) | 2003-11-23 |
| AR035923A1 (en) | 2004-07-28 |
| DE10150312A1 (en) | 2002-07-04 |
| SK4342003A3 (en) | 2003-10-07 |
| YU28203A (en) | 2006-05-25 |
| JP2004511547A (en) | 2004-04-15 |
| BR0114603A (en) | 2003-10-14 |
| NO20031697D0 (en) | 2003-04-11 |
| PL361359A1 (en) | 2004-10-04 |
| AU2002215943A1 (en) | 2002-04-29 |
| MXPA03003162A (en) | 2004-12-06 |
| CZ20031333A3 (en) | 2003-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200200873A1 (en) | NEW PIPERAZINE DERIVATIVES | |
| DE60140456D1 (en) | AZA HETEROCYCLIC DERIVATIVES AND ITS THERAPEUTIC USE | |
| TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
| ATE302775T1 (en) | CARBOLINE DERIVATIVES | |
| EA200201179A1 (en) | DERIVATIVES 2-AMINOKARBONIL-9H-PURINA | |
| DK0977741T3 (en) | Substituted phenyl derivatives, their preparation and use | |
| EA200300674A1 (en) | OBTAINING HETEROCYCLIC SULPHONAMIDE INHIBITORS BETA-AMYLOID | |
| EA200100411A1 (en) | SUBSTITUTED 3-CYANOHINOLINES AS PROTEINTHYROSINKINASE INHIBITORS | |
| DE60237145D1 (en) | quinazoline derivatives | |
| EA200100412A1 (en) | SUBSTITUTED 3-CYANOHINOLINES AS PROTEINTHYROSINKINASE INHIBITORS | |
| SE9904176D0 (en) | New use | |
| SE9903760D0 (en) | New compounds | |
| DK1159279T3 (en) | 4-Oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antivirals | |
| AU7927591A (en) | Substituted aminoalkylbiphenyl derivatives | |
| ES2189968T3 (en) | Amidinophenyl-pyrrolidines, -pyrrolines, e -isoxazolidines and derivatives thereof. | |
| ATE346067T1 (en) | CARBOLINE DERIVATIVES | |
| EA200300619A1 (en) | SEROTONINERGIC MEANS | |
| ATE300543T1 (en) | CONDENSED PYRAZINEDIONE DERIVATIVES AS PDE5 INHIBITERS | |
| EA200200876A1 (en) | Alkylated Imidazopyridine Derivatives | |
| EA200300392A1 (en) | Derivatives of piperazine with a bridge connection | |
| DE60112960D1 (en) | CONDENSED PYRIDOINDOL DERIVATIVES | |
| DK1204658T3 (en) | Benzofurylpiperazine-serotonin agonists | |
| DE60121048D1 (en) | PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| DE69330601D1 (en) | SEROTON INERGIC ERGOLIN DERIVATIVES | |
| NO890440L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ISOKINOLINE DERIVATIVES. |